Corcept Therapeutics reported $533.26M in Assets for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acadia Pharmaceuticals ACAD:US USD 602.49M 10.28M
Ani Pharmaceuticals ANIP:US USD 739.11M 12.22M
Ardelyx ARDX:US USD 144.67M 13.06M
Aurora Cannabis Inc ACB:CN CAD 1.17B 85.57M
Biomarin Pharmaceutical BMRN:US USD 6.26B 118.2M
Canopy Growth Corp WEED:CN CAD 3.4B 115.26M
Corcept Therapeutics CORT:US USD 533.26M 36.89M
Depomed DEPO:US USD 323.34M 1.37M
Esperion Therapeutics ESPR:US USD 312.83M 8.85M
Knight Therapeutics Inc GUD:CN CAD 1.04B 34.21M
Lannett LCI:US USD 438.36M 28.94M
Lexicon Pharmaceuticals LXRX:US USD 191.68M 79.36M
Nektar Therapeutics NKTR:US USD 781.01M 80.98M
Novartis NOVN:VX USD 118.46B 4.45B
Novartis NVS:US USD 117.45B 1.01B
Omeros OMER:US USD 457.55M 111.91M
Pacira Pharmaceuticals PCRX:US USD 1.73B 377K
Supernus Pharmaceuticals SUPN:US USD 1.69B 1.84M
Tg Therapeutics TGTX:US USD 217.89M 33.78M
Ziopharm Oncology ZIOP:US USD 67.34M 6.59M